Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Journal of Receptor and Signal Transduction Research
|
July 18, 2019
Discovery of human autophagy initiation kinase ULK1 inhibitors by multi-directional <i>in silico</i> screening strategies
Poornimaa Mu, Ramanathan Karuppasamy
Journal of Molecular Modeling
|
December 9, 2022
Exploration of natural product database for the identification of potent inhibitor against IDH2 mutational variants for glioma therapy
Poornimaa Murali, Ramanathan Karuppasamy
Protoplasma
|
March 4, 2025
Seaweed-based PPO inhibitors as a new frontier in biological weed control for sorghum cultivation: from ocean to field
Renuka Suresh, Ramanathan Karuppasamy
Natural Product Research
|
December 5, 2022
Bioherbicides for sustainable barnyard grass management in paddy field: an in-silico perspective
Ajitha Antony, Ramanathan Karuppasamy
Anti-Cancer Agents in Medicinal Chemistry
|
January 26, 2023
Imidazole and Biphenyl Derivatives as Anti-cancer Agents for Glioma Therapeutics: Computational Drug Repurposing Strategy
Poornimaa Murali, Ramanathan Karuppasamy
BMC Plant Biology
|
July 6, 2026
Comparative transcriptomic analysis identifies conserved abiotic stress-responsive hub genes in Sorghum bicolor
Renuka Suresh, Ramanathan Karuppasamy
Biotechnology and Applied Biochemistry
|
November 26, 2024
Deciphering the prognostic landscape of triple-negative breast cancer: A focus on immune-related hub genes and therapeutic implications
HemaNandini Rajendran Krishnamoorthy, Ramanathan Karuppasamy
Journal of Biopharmaceutical Statistics
|
November 18, 2022
Forecasting determinants of recurrence in lung cancer patients exploiting various machine learning models
Muthu Kumar Thirunavukkarasu, Ramanathan Karuppasamy
Journal of Biomolecular Structure & Dynamics
|
August 30, 2021
Drug repurposing combined with MM/PBSA based validation strategies towards MEK inhibitors screening
Muthu Kumar Thirunavukkarasu, Ramanathan Karuppasamy
In Silico Pharmacology
|
January 12, 2026
Design and optimization of peptidomimetics as PD-1/PD-L1 modulators for the management of triple-negative breast cancer
HemaNandini Rajendran Krishnamoorthy, Ramanathan Karuppasamy
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Journal of Receptor and Signal Transduction Research
|
July 18, 2019
Discovery of human autophagy initiation kinase ULK1 inhibitors by multi-directional <i>in silico</i> screening strategies
Poornimaa Mu, Ramanathan Karuppasamy
Journal of Molecular Modeling
|
December 9, 2022
Exploration of natural product database for the identification of potent inhibitor against IDH2 mutational variants for glioma therapy
Poornimaa Murali, Ramanathan Karuppasamy
Protoplasma
|
March 4, 2025
Seaweed-based PPO inhibitors as a new frontier in biological weed control for sorghum cultivation: from ocean to field
Renuka Suresh, Ramanathan Karuppasamy
Natural Product Research
|
December 5, 2022
Bioherbicides for sustainable barnyard grass management in paddy field: an in-silico perspective
Ajitha Antony, Ramanathan Karuppasamy
Anti-Cancer Agents in Medicinal Chemistry
|
January 26, 2023
Imidazole and Biphenyl Derivatives as Anti-cancer Agents for Glioma Therapeutics: Computational Drug Repurposing Strategy
Poornimaa Murali, Ramanathan Karuppasamy
BMC Plant Biology
|
July 6, 2026
Comparative transcriptomic analysis identifies conserved abiotic stress-responsive hub genes in Sorghum bicolor
Renuka Suresh, Ramanathan Karuppasamy
Biotechnology and Applied Biochemistry
|
November 26, 2024
Deciphering the prognostic landscape of triple-negative breast cancer: A focus on immune-related hub genes and therapeutic implications
HemaNandini Rajendran Krishnamoorthy, Ramanathan Karuppasamy
Journal of Biopharmaceutical Statistics
|
November 18, 2022
Forecasting determinants of recurrence in lung cancer patients exploiting various machine learning models
Muthu Kumar Thirunavukkarasu, Ramanathan Karuppasamy
Journal of Biomolecular Structure & Dynamics
|
August 30, 2021
Drug repurposing combined with MM/PBSA based validation strategies towards MEK inhibitors screening
Muthu Kumar Thirunavukkarasu, Ramanathan Karuppasamy
In Silico Pharmacology
|
January 12, 2026
Design and optimization of peptidomimetics as PD-1/PD-L1 modulators for the management of triple-negative breast cancer
HemaNandini Rajendran Krishnamoorthy, Ramanathan Karuppasamy
Page
of 5